PharmiWeb.com - Global Pharma News & Resources
06-Sep-2019

6.6%+ Growth for Interventional Cardiology Devices Market 2019 – 2028 | Growth Forecast & Industry Share Report

New York City, NY: Sept 06, 2019 – Published via (Wired Release) – Interventional cardiology is a specialty area within the larger field of cardiology. Interventional cardiology is a branch of cardiology that deals specifically with catheter-based treatment of structural heart diseases. Interventional cardiology devices are equipment that is used for carrying out surgical processes of heart.

The global interventional cardiology devices market is expected to value at approximately US$ 11.1 Bn in 2019 and is expected to register a CAGR of 6.6%. 

Global Interventional Cardiology Devices Market: Dynamics

Increasing incidence of cardiovascular diseases across globe is a major factor expected to drive the growth of the global interventional cardiology devices market. In addition, increasing geriatric population across the globe, increasing government expenditure for development of healthcare infrastructure, availability of favorable reimbursement policies across various countries in the developed regions such as US, Canada, UK, and certain developing countries of Asia Pacific are some of the factors expected to drive the growth of the target market.

Request For Sample Report Before Buying: https://marketresearch.biz/report/interventional-cardiology-devices-market/request-sample/

The high manufacturing cost of medical devices, coupled with the availability of cost-effective devices offered by domestic players is resulting in increasing pressure on major players to cut down prices of devices and is a factor expected to restraint the growth of the target market to a significant extent.

Prominent players are focused on adopting extensive expansion through merger and acquisition, collaboration activities in order to enhance product portfolio as well as expand its geographical footprint. For instance, in 2017, Abbott Laboratories received CE Mark for XIENCE Sierra, everolimus-eluting coronary stent system. The objective of this is to strengthen its product portfolio and expand its business in Europe. The aforementioned is a key trend witnessed in the target market currently.

Global Interventional Cardiology Devices Market: Market Forecast

The comprehensive research report comprises a complete forecast of the global interventional cardiology devices market based on factors affecting the market and their impact in the foreseeable future. According to the forecast projections, revenue from the global interventional cardiology devices market is expected to expand at a CAGR of over 6.6% over the forecast period.

Inquire for Further Detailed Information About The Report Before Buying: https://marketresearch.biz/report/interventional-cardiology-devices-market/#inquiry

Global Interventional Cardiology Devices Market: Segmental Snapshot

The market report has been segmented on the basis of product type, end user, and region. The product type segments include stents, balloon catheters, cutting balloon, guidewires, guide catheters, angiographic catheters, intravascular ultrasound imaging system, atherectomy devices, and others. The end user segments include hospitals, ambulatory surgical centers, and specialty clinics. The regions covered in the analysis include North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

By Product Type: The stents purifier segment is expected to account for highest revenue share contribution as compared to other product type segments, and is expected to register highest CAGR of over 6.7% over the forecast period

By End User: The hospital’s segment is projected to account for highest revenue share as compared to that of other end user segments, and projected to register highest CAGR of over 6.7% over the forecast period

By Region: The market in North America accounted for the highest revenue share in the global interventional cardiology devices market. The market in the Asia Pacific is projected to register the highest CAGR of over 7% during the forecast period.

Browse More Insight Of This Premium Research Report Enabled with Respective Tables and Figures at: https://marketresearch.biz/report/interventional-cardiology-devices-market/

Global Interventional Cardiology Devices Market: Competitive Analysis

The research report on the global interventional cardiology devices market include profiles of some of major companies such as Cardinal Health, Inc., Blue Sail Medical Co., Ltd. (Biosensors International Group, Ltd.), Abbott Laboratories, Medtronic plc, B. Braun Melsungen AG, Boston Scientific Corporation, Terumo Corporation, Koninklijke Philips N.V., Cardiovascular Systems, Inc., and Johnson & Johnson

About Us:

MarketResearch.Biz is a specialized market research, analytics, and solutions company, offering strategic and tactical support to clients for making well-informed business decisions. We are a team of dedicated and impassioned individuals, who believe strongly in giving our very best to what we do and we never back down from any challenge. It offers services such as data mining, information management, and revenue enhancement solutions and suggestions.

Contact Us:

Mr. Benni Johnson
Prudour Pvt. Ltd.
420 Lexington Avenue,
Suite 300 New York City, NY 10170,
United States
Tel: + 1-347-826-1876
Email ID: inquiry@marketresearch.biz
Website: https://marketresearch.biz/

Editor Details

Last Updated: 06-Sep-2019